Higher levels of IL-33 have been found in the tumor tissues of ESCC patients than in adjacent normal tissues, also appearing closely related to ESCC progression, invasive depth, degree of differentiation, TNM stage, and worse clinical outcomes [88], although without a clear correlation with overall survival. The gene discussed is IL33; the disease is esophageal squamous cell carcinoma.